Position in VTRS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$14,718,874
+$2,367,727 QoQ
Shares Held
1,089,480
+9.8% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ALGERT GLOBAL LLC holds $52,013,067 across 12 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (28.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
1,089,480 | $14,718,874 | |
| 2 | LQDA |
Liquidia Corp
|
204,060 | $7,701,224 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,156,958 | $6,710,356 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
222,840 | $5,332,561 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
355,929 | $4,424,197 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
6,160 | $3,652,756 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
47,568 | $2,630,986 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
19,970 | $2,630,847 |
All Filings in VTRS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,718,874 | 1,089,480 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $12,351,147 | 992,060 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,313,230 | 637,700 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||